Help the FDA learn more about the impact of FGIDs
Are you someone whose life is impacted by a functional GI disorder like IBS, gastroparesis, GERD symptoms despite standard therapy, or chronic constipation? If so, the US Food and Drug Administration (FDA) wants to hear from you. On May 11, 2015, the FDA is holding a public meeting on Functional GI Patient-Focused Drug Development. You can join them in person, via live meeting webcast, or by sharing comments through a public docket. Let your voice be heard by sharing your input on daily life with a functional GI disorder, as well as views on current available therapies.
|